Larimar Therapeutics, Inc. · NASDAQ:LRMR
BlackRock, Inc.'s stake in Larimar Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 22, 2025
BlackRock, Inc.'s stake in Larimar Therapeutics, Inc. fell to 4.80%, 3,079,665 shares, as a passive investor on Mar 31, 2025. Filed Apr 22, 2025 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 3,079,665
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.80% | 3,079,665 |
Source
Related
- Larimar Therapeutics, Inc.
- BlackRock, Inc.
- Larimar Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026